MedTrace Logo

Establishment of Drug-induced Liver Injury Databases and Application of Circulating microRNA(miRNA)

NCT02061826 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2014-02-19

No results posted yet for this study

Summary

The purpose of the study is to establish drug-induced liver injury databases in China, make criteria for Chinese drug-induced liver injury patients and evaluate the application of certain circulating miRNA in diagnosis or treatment of drug-induced liver injury.

Conditions

  • Drug-induced Liver Injury

Sponsors & Collaborators

  • Beijing Ditan Hospital

    lead OTHER

Principal Investigators

  • Wen Xie, master · Beijing Ditan Hospital

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02061826 on ClinicalTrials.gov